164 related articles for article (PubMed ID: 35116358)
1. High expression of SETDB1 mediated by miR-29a-3p associates with poor prognosis and immune invasion in breast invasive carcinoma.
Chen X; Li X; Wei C; Zhao C; Wang S; Gao J
Transl Cancer Res; 2021 Dec; 10(12):5065-5075. PubMed ID: 35116358
[TBL] [Abstract][Full Text] [Related]
2. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation.
Wu M; Fan B; Guo Q; Li Y; Chen R; Lv N; Diao Y; Luo Y
Biol Res; 2018 Oct; 51(1):39. PubMed ID: 30309377
[TBL] [Abstract][Full Text] [Related]
4. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma.
Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H
Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557
[TBL] [Abstract][Full Text] [Related]
6. A regulatory circuitry comprising TP53,
Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
[TBL] [Abstract][Full Text] [Related]
7. Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors.
Lin X; Xiao M; Chen Z; Ding C; Zhang T; Li Q
J Oncol; 2022; 2022():6115878. PubMed ID: 35656340
[TBL] [Abstract][Full Text] [Related]
8. Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation.
Singh SK; Bahal R; Rasmussen TP
Exp Cell Res; 2020 Oct; 395(2):112216. PubMed ID: 32768498
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
[No Abstract] [Full Text] [Related]
10. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
[TBL] [Abstract][Full Text] [Related]
11. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
12. SETDB1 promotes progression through upregulation of SF3B4 expression and regulates the immunity in ovarian cancer.
Yang H; Sui L; Cai C; Chu H; Diao Y
J Ovarian Res; 2024 Feb; 17(1):34. PubMed ID: 38317200
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
He L; Lin Y; Huang P; Pan H
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152
[TBL] [Abstract][Full Text] [Related]
14. Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma.
Wang C; Xia Z; Li Z; Ye F; Ji S; Lu C; Zhang H
J Clin Lab Anal; 2022 Jan; 36(1):e24090. PubMed ID: 34843122
[TBL] [Abstract][Full Text] [Related]
15. PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer.
Chen Z; Zhong S; Zhang Z; Tang J
Biochem Genet; 2023 Aug; 61(4):1369-1386. PubMed ID: 36598702
[TBL] [Abstract][Full Text] [Related]
16. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
[TBL] [Abstract][Full Text] [Related]
17. DCTPP1, an Oncogene Regulated by miR-378a-3p, Promotes Proliferation of Breast Cancer via DNA Repair Signaling Pathway.
Niu M; Shan M; Liu Y; Song Y; Han JG; Sun S; Liang XS; Zhang GQ
Front Oncol; 2021; 11():641931. PubMed ID: 34113564
[TBL] [Abstract][Full Text] [Related]
18. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
19. A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer.
Lian W; Yang P; Li L; Chen D; Wang C
Front Med (Lausanne); 2023; 10():1194046. PubMed ID: 37275369
[TBL] [Abstract][Full Text] [Related]
20. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
Ling J; Peng N; Luo L
J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
